InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,233.07
(
0.23%
)
Post# of 255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 138
Posts 23139
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: georgejjl post# 148

Saturday, 04/10/2021 10:55:29 PM

Saturday, April 10, 2021 10:55:29 PM

Post# of 255
Cohort 3 should be AMAZING with 3X the TU of Cohort 2

Volume Expansion
Cohort 3
4.2 x 107 TU
1800 µL total infusion volume

Gating item for filing
> Developing reliable, suspension-based manufacturing process
> Oxford Biomedica has initiated the manufacture of GMP batches
using this process

Oxford BioMedica should have capacity soon now that the Oxford/Astrazeneca vaccine production may be taking up less capacity at Oxford BioMedica.

Good luck and GOD bless,
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up